Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$42.9M
Filings
121
Firms Hired
3
Active Period
1999–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Improving Seniors’ Timely Access to Care Act of 2025
2026 · third_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); laboratory coding, pricing, coverage, and payment; Improving Seniors' Timely Access to Care Act (H.R. 3514/S. 1816); Prior Authorization Accountability Act (H.R. 9396); program integrity initiatives.
Client expense: $850,000 · Firm income: —
Matched citations: H.R. 3514
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); laboratory services as Essential Health Benefits; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393); Health Care Price Certainty for All Americans Act (H.R. 9645); Prices on the Wall Act of 2026 (H.R. 9390).
Client expense: $850,000 · Firm income: —
Matched citations: H.R. 5269
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); laboratory coding, pricing, coverage, and payment; Improving Seniors' Timely Access to Care Act (H.R. 3514/S. 1816); Prior Authorization Accountability Act (H.R. 9396); program integrity initiatives.
Client expense: $850,000 · Firm income: —
Matched citations: H.R. 5269
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); artificial intelligence in laboratory services; Timely Access to Coverage Decisions Act (H.R. 8500); laboratory services as Essential Health Benefits; laboratory coding, pricing, coverage, and payment.
Client expense: $850,000 · Firm income: —
Matched citations: H.R. 5269
Patients Deserve Price Tags Act
2026 · third_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); laboratory services as Essential Health Benefits; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393); Health Care Price Certainty for All Americans Act (H.R. 9645); Prices on the Wall Act of 2026 (H.R. 9390).
Client expense: $850,000 · Firm income: —
Matched citations: H.R. 5582
H–1Bs for Physicians and the Healthcare Workforce Act
2026 · third_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
H-1Bs for Physicians and Healthcare Workforce Act (H.R. 7961).
Client expense: $850,000 · Firm income: —
Matched citations: H.R. 7961
Timely Access to Coverage Decisions Act of 2026
2026 · third_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); artificial intelligence in laboratory services; Timely Access to Coverage Decisions Act (H.R. 8500); laboratory services as Essential Health Benefits; laboratory coding, pricing, coverage, and payment.
Client expense: $850,000 · Firm income: —
Matched citations: H.R. 8500
Protect Domestic Oil and Gas Small Business Act of 2026
2026 · third_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); artificial intelligence in laboratory services; Timely Access to Coverage Decisions Act (H.R. 8500); laboratory services as Essential Health Benefits; laboratory coding, pricing, coverage, and payment.
Client expense: $850,000 · Firm income: —
Matched citations: H.R. 8990
Protect Domestic Oil and Gas Small Business Act of 2026
2026 · third_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); laboratory services as Essential Health Benefits; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393); Health Care Price Certainty for All Americans Act (H.R. 9645); Prices on the Wall Act of 2026 (H.R. 9390).
Client expense: $850,000 · Firm income: —
Matched citations: H.R. 8990
Prices on the Wall Act of 2026
2026 · third_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); laboratory services as Essential Health Benefits; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393); Health Care Price Certainty for All Americans Act (H.R. 9645); Prices on the Wall Act of 2026 (H.R. 9390).
Client expense: $850,000 · Firm income: —
Matched citations: H.R. 9390
Lower Costs, More Transparency Act of 2026
2026 · third_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); laboratory services as Essential Health Benefits; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393); Health Care Price Certainty for All Americans Act (H.R. 9645); Prices on the Wall Act of 2026 (H.R. 9390).
Client expense: $850,000 · Firm income: —
Matched citations: H.R. 9393
Prior Authorization Accountability Act
2026 · third_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); laboratory coding, pricing, coverage, and payment; Improving Seniors' Timely Access to Care Act (H.R. 3514/S. 1816); Prior Authorization Accountability Act (H.R. 9396); program integrity initiatives.
Client expense: $850,000 · Firm income: —
Matched citations: H.R. 9396
Health Care Price Certainty for All Americans Act
2026 · third_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); laboratory services as Essential Health Benefits; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393); Health Care Price Certainty for All Americans Act (H.R. 9645); Prices on the Wall Act of 2026 (H.R. 9390).
Client expense: $850,000 · Firm income: —
Matched citations: H.R. 9645
Improving Seniors’ Timely Access to Care Act of 2025
2026 · third_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); laboratory coding, pricing, coverage, and payment; Improving Seniors' Timely Access to Care Act (H.R. 3514/S. 1816); Prior Authorization Accountability Act (H.R. 9396); program integrity initiatives.
Client expense: $850,000 · Firm income: —
Matched citations: S. 1816
Patients Deserve Price Tags Act
2026 · third_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); laboratory services as Essential Health Benefits; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393); Health Care Price Certainty for All Americans Act (H.R. 9645); Prices on the Wall Act of 2026 (H.R. 9390).
Client expense: $850,000 · Firm income: —
Matched citations: S. 2355
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); artificial intelligence in laboratory services; Timely Access to Coverage Decisions Act (H.R. 8500); laboratory services as Essential Health Benefits; laboratory coding, pricing, coverage, and payment.
Client expense: $850,000 · Firm income: —
Matched citations: S. 2761
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); laboratory services as Essential Health Benefits; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393); Health Care Price Certainty for All Americans Act (H.R. 9645); Prices on the Wall Act of 2026 (H.R. 9390).
Client expense: $850,000 · Firm income: —
Matched citations: S. 2761
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); laboratory coding, pricing, coverage, and payment; Improving Seniors' Timely Access to Care Act (H.R. 3514/S. 1816); Prior Authorization Accountability Act (H.R. 9396); program integrity initiatives.
Client expense: $850,000 · Firm income: —
Matched citations: S. 2761
Improving Seniors’ Timely Access to Care Act of 2025
2026 · second_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); laboratory coding, pricing, coverage, and payment; Improving Seniors' Timely Access to Care Act (H.R. 3514/S. 1816); Prior Authorization Accountability Act (H.R. 9396); program integrity initiatives.
Client expense: $890,000 · Firm income: —
Matched citations: H.R. 3514
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); laboratory coding, pricing, coverage, and payment; Improving Seniors' Timely Access to Care Act (H.R. 3514/S. 1816); Prior Authorization Accountability Act (H.R. 9396); program integrity initiatives.
Client expense: $890,000 · Firm income: —
Matched citations: H.R. 5269
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393).
Client expense: $890,000 · Firm income: —
Matched citations: H.R. 5269
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; artificial intelligence in laboratory services; laboratory coding, pricing, coverage, and payment.
Client expense: $890,000 · Firm income: —
Matched citations: H.R. 5269
Patients Deserve Price Tags Act
2026 · second_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393).
Client expense: $890,000 · Firm income: —
Matched citations: H.R. 5582
H–1Bs for Physicians and the Healthcare Workforce Act
2026 · second_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
H-1Bs for Physicians and Healthcare Workforce Act (H.R. 7961).
Client expense: $890,000 · Firm income: —
Matched citations: H.R. 7961
Lower Costs, More Transparency Act of 2026
2026 · second_quarter · Firm: AMERICAN CLINICAL LABORATORY ASSN
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393).
Client expense: $890,000 · Firm income: —
Matched citations: H.R. 9393
Source: Senate LDA